Sequenom and the Sequenom Center for Molecular Medicine are dedicated to improving the availability of diagnostic approaches to detecting medical conditions and diseases by developing novel nucleic acid based in vitro diagnostic tests. The members of the Sequenom Prenatal Clinical Advisory Board work with the company to provide guidance in the development of all facets of prenatal diagnostics, including the use of circulating cell free nucleic acid technology. The Clinical Advisory Board members bring together a full complement of solid expertise in Obstetrics and Gynecology, Maternal Fetal Medicine, Clinical Genetics, and applied clinical research.